VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis

Cancer Letters

Volumn 208, Issue 2, 2004, Pages 215-225

  Bandoh, Nobuyuki ^a   Hayashi, Tatsuya ^a   Takahara, Miki ^a   Kishibe, Kan ^a   Ogino, Takeshi ^a   Katayama, Akihiro ^a   Imada, Masanobu ^a   Nonaka, Satoshi ^a   Harabuchi, Yasuaki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

basic fibroblast growth factor; Maxillary sinus squamous cell carcinoma; Microvessel density; p53; Prognosis; Spontaneous apoptosis; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD31 ANTIGEN; FLUOROURACIL; MONOCLONAL ANTIBODY; PROTEIN P53; SINGLE STRANDED DNA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MAXILLA RESECTION; MAXILLA SINUS CARCINOMA; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR BIOPSY; TUMOR CELL;

ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAXILLARY SINUS NEOPLASMS; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2442479597     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.11.031     Document Type: Article

References (51)

1. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31
3. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1-8
4. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E.N., Moore D.H., et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84:1992;1875-1887
5. Senger D.R., Van de Water L., Brown L.F., Nagy J.A., Yeo K.T., Yeo T.K., et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12:1993;303-324
6. Moriyama M., Kumagai S., Kawashiri S., Kojima K., Kakihara K., Yamamoto E. Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol. 33:1997;369-374
7. Salven P., Heikkila P., Anttonen A., Kajanti M., Joensuu H. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod. Pathol. 10:1997;1128-1133
8. Maeda T., Matsumura S., Hiranuma H., Jikko A., Furukawa S., Ishida T., Fuchihata H. Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status. J. Clin. Pathol. 51:1998;771-775
9. Burian M., Quint C., Neuchrist C. Angiogenic factors in laryngeal carcinomas: do they have prognostic relevance? Acta Otolaryngol. 119:1999;289-292
10. Eisma R.J., Spiro J.D., Kreutzer D.L. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma. Laryngoscope. 109:1999;687-693
11. Neuchrist C., Quint C., Pammer A., Burian M. Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol. 119:1999;732-738
12. Sauter E.R., Nesbit M., Watson J.C., Klein-Szanto A., Litwin S., Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin. Cancer Res. 5:1999;775-782
13. Mineta H., Miura K., Ogino T., Takebayashi S., Misawa K., Ueda Y., et al. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br. J. Cancer. 83:2000;775-781
14. Hughes C.J., Reed J.A., Cabal R., Huvos A.G., Albino A.P., Schantz S.P. Increased expression of basic fibroblast growth factor in squamous carcinogenesis of the head and neck is less prevalent following smoking cessation. Am. J. Surg. 168:1994;381-385
15. Dellacono F.R., Spiro J., Eisma R., Kreutzer D. Expression of basic fibroblast growth factor and its receptors by head and neck squamous carcinoma tumor and vascular endothelial cells. Am. J. Surg. 174:1997;540-544
16. Riedel F., Gotte K., Schwalb J., Schafer C., Hormann K. Vascular endothelial growth factor expression correlates with p53 mutation and angiogenesis in squamous cell carcinoma of the head and neck. Acta Otolaryngol. 120:2000;105-111
17. Gasparini G., Weidner N., Maluta S., Pozza F., Boracchi P., Mezzetti M., et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int. J. Cancer. 55:1993;739-744
18. Williams J.K., Carlson G.W., Cohen C., Derose P.B., Hunter S., Jurkiewicz M.J. Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am. J. Surg. 168:1994;373-380
19. Dray T.G., Hardin N.J., Sofferman R.A. Angiogenesis as a prognostic marker in early head and neck cancer. Ann. Otol. Rhinol. Laryngol. 104:1995;724-729
20. Zatterstrom U.K., Brun E., Willen R., Kjellen E., Wennerberg J. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck. 17:1995;312-318
21. Murray J.D., Carlson G.W., McLaughlin K., Pennington M., Lynn M., DeRose P.B., et al. Tumor angiogenesis as a prognostic factor in laryngeal cancer. Am. J. Surg. 174:1997;523-526
22. Kamijo T., Yokose T., Hasebe T., Yonou H., Sasaki S., Hayashi R., et al. Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy. Clin. Cancer Res. 6:2000;3159-3165
23. Ito Y., Kamijo T., Yokose T., Kawashima M., Ogino T., Ikeda H., et al. Microvessel density predicts the radiosensitivity of metastatic head and neck squamous cell carcinoma in cervical lymph nodes. Int. J. Oncol. 19:2001;1127-1132
24. Wakisaka N., Wen Q.H., Yoshizaki T., Nishimura T., Furukawa M., Kawahara E., Nakanishi I. Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma. Laryngoscope. 109:1999;810-814
25. Riedel F., Gotte K., Bergler W., Rojas W., Hormann K. Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer. Head Neck. 22:2000;183-189
26. Bandoh N., Hayashi T., Kishibe K., Takahara M., Imada M., Nonaka S., Harabuchi Y. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma. Cancer. 94:2002;1968-1980
27. Kondo Y., Arii S., Furutani M., Isigami S., Mori A., Onodera H., et al. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma. Cancer. 88:2000;1820-1827
28. Fontanini G., Vignati S., Lucchi M., Mussi A., Calcinai A., Boldrini L., et al. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br. J. Cancer. 75:1997;1295-1301
29. Linderholm B., Lindh B., Tavelin B., Grankvist K., Henriksson R. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int. J. Cancer. 89:2000;51-62
30. Lu C., Rak J.W., Kobayashi H., Kerbel R.S. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Cancer Res. 53:1993;2708-2711
31. Ikeguchi M., Cai J., Yamane N., Maeta M., Kaibara N. Clinical significance of spontaneous apoptosis in advanced gastric adenocarcinoma. Cancer. 85:1999;2329-2335
32. Ikeguchi M., Cai J., Fukuda K., Oka S., Katano K., Tsujitani S., et al. Correlation between spontaneous apoptosis and the expression of angiogenic factors in advanced gastric adenocarcinoma. J. Exp. Clin. Cancer Res. 20:2001;257-263
33. Koide N., Nishio A., Kono T., Yazawa K., Igarashi J., Watanabe H., et al. Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus. Hepatogastroenterology. 46:1999;952-958
34. Riedel F., Gotte K., Bergler W., Hormann K. Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck. Oncol. Rep. 8:2001;471-476
35. Miyake H., Hara I., Gohji K., Yoshimura K., Arakawa S., Kamidono S. Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line. Cancer Lett. 123:1998;121-126
36. Hayashi T., Nonaka S., Bandoh N., Kobayashi Y., Imada M., Harabuchi Y. Treatment of maxillary sinus carcinoma. Cancer. 92:2001;1495-1503
37. Shimosato Y., Oboshi S., Baba K. Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn. J. Clin. Oncol. 1:1971;19-35
38. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat. 36:1995;127-137
39. Terman B.I., Dougher-Vermazen M. Biological properties of VEGF/VPF receptors. Cancer Metastasis Rev. 15:1996;159-163
40. Kieser A., Weich H.A., Brandner G., Marme D., Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene. 9:1994;963-969
41. Mukhopadhyay D., Tsiokas L., Sukhatme V.P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res. 55:1995;6161-6165
42. Bouvet M., Ellis L.M., Nishizaki M., Fujiwara T., Liu W., Bucana C.D., Fang B., Lee J.J., Roth J.A. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res. 58:1998;2288-2292
43. Holmgren L., O'Reilly M.S., Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1:1995;149-153
44. O'Reilly M.S., Holmgren L., Chen C., Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2:1996;689-692
45. Graeber T.G., Peterson J.F., Tsai M., Monica K., Fornace A.J. Jr., Giaccia A.J. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:1994;6264-6277
46. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967
47. Giaccia A.J. Hypoxic stress proteins: survival of the fittest. Semin. Radiat. Oncol. 6:1996;46-58
48. Gupta K., Kshirsagar S., Li W., Gui L., Ramakrishnan S., Gupta P., Law P.Y., Hebbel R.P. VGEF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp. Cell Res. 247:1999;495-504
49. Nor J.E., Christensen J., Mooney D.J., Polverini P.J. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am. J. Pathol. 154:1999;375-384
50. Suit H., Allam A., Allalunis-Turner J., Brock W., Girinsky T., Hill S., Hunter N., Milas L., Pearcey R., Peters L., et al. Is tumor cell radiation resistance correlated with metastatic ability? Cancer Res. 54:1994;1736-1741
51. Galy B., Creancier L., Zanibellato C., Prats A.C., Prats H. Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism. Oncogene. 20:2001;1669-1677